TrialJournal of gastroenterology2018

Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.

Atsushi Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.